메뉴 건너뛰기




Volumn 106, Issue 1, 2015, Pages 8-

Status of P2Y12 treatment must be considered in evaluation of myocardial ischaemia/reperfusion injury

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR;

EID: 84926676612     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvv051     Document Type: Letter
Times cited : (5)

References (6)
  • 4
    • 84885172325 scopus 로고    scopus 로고
    • Triple therapy increased myocardial salvage during ischemia/reperfusion in the in situ rat heart
    • Yang X-M, Cui L, Alhammouri A, Downey JM, Cohen MV. Triple therapy increased myocardial salvage during ischemia/reperfusion in the in situ rat heart. Cardiovasc Drugs Ther 2013;27:403-412
    • (2013) Cardiovasc Drugs Ther , vol.27 , pp. 403-412
    • Yang, X.-M.1    Cui, L.2    Alhammouri, A.3    Downey, J.M.4    Cohen, M.V.5
  • 5
    • 84894428436 scopus 로고    scopus 로고
    • Combined cardioprotectant and antithrombotic actions of platelet p2y12 receptor antagonists in acute coronary syndrome: Just what the doctor ordered
    • Cohen MV, Downey JM.Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered. J Cardiovasc Pharmacol Ther 2014;19: 179-190
    • (2014) J Cardiovasc Pharmacol Ther , vol.19 , pp. 179-190
    • Cohen, M.V.1    Downey, J.M.2
  • 6
    • 84925852648 scopus 로고    scopus 로고
    • Signalling pathways and mechanisms of protection in pre-and postconditioning: Historical perspective and lesions for the future
    • in press
    • Cohen MV, Downey JM. Signalling pathways and mechanisms of protection in pre-and postconditioning: historical perspective and lesions for the future. Br J Pharmacol 2015; in press
    • (2015) Br J Pharmacol
    • Cohen, M.V.1    Downey, J.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.